威尼斯人
髓系白血病
医学
肿瘤科
危险分层
内科学
低甲基化剂
白血病
重症监护医学
基因
生物
遗传学
DNA甲基化
慢性淋巴细胞白血病
基因表达
作者
Curtis A. Lachowiez,Vishvaas I Ravikumar,Jad Othman,Jenny O’Nions,D. Peters,Christine M. McMahon,Ronan T. Swords,Rachel C. Cook,Jennifer N. Saultz,Jeffrey W. Tyner,Richard Dillon,Joshua F. Zeidner,Daniel A. Pollyea
出处
期刊:Blood
[Elsevier BV]
日期:2024-11-01
被引量:2
标识
DOI:10.1182/blood.2024026925
摘要
The ELN 2024 risk-stratification guidelines for patients with acute myeloid leukemia receiving hypomethylating agents combined with venetoclax were recently published. This analysis demonstrates re-classification and incorporation of new gene mutations in the present model can further improve and individualize prognostication.
科研通智能强力驱动
Strongly Powered by AbleSci AI